Skip to main content
SpringerLink
Log in

Preoperative Evaluation of the Patient with Medullary Thyroid Cancer

  • Chapter
  • First Online:
Medullary Thyroid Cancer

  • 664 Accesses

Abstract

Medullary thyroid carcinoma (MTC) represents only 1–2 % of all thyroid cancers in the USA [1]. Although MTC is relatively rare, optimal management requires the clinician to be familiar with the details of genetics, pathology, endocrinology, surgery, and radiology that specifically pertain to MTC. The purpose of this chapter is to summarize the current standard-of-care preoperative evaluation of the patient with MTC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 2015;25:567–610.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kebebew E, Ituarte PH, Siperstein AE, et al. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139–48.

    Article  CAS  PubMed  Google Scholar 

  3. Moley JF. Medullary thyroid carcinoma: management of lymph node metastases. J Natl Compr Canc Netw. 2010;8:549–56.

    PubMed  Google Scholar 

  4. Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline: improving voice outcomes after thyroid surgery. Otolaryngol Head Neck Surg. 2013;148:S1–37.

    Article  PubMed  Google Scholar 

  5. Jarhult J, Lindestad PA, Nordenstrom J, Perbeck L. Routine examination of the vocal cords before and after thyroid and parathyroid surgery. Br J Surg. 1991;78:1116–7.

    Article  CAS  PubMed  Google Scholar 

  6. Callender GG, Carling T, Christison-Lagay E, Udelsman R. Surgery for thyroid cancer. Endocrinol Metab Clin North Am. 2014;43:443–58.

    Article  PubMed  Google Scholar 

  7. Randolph GW. The importance of pre and postoperative laryngeal examination for thyroid surgery. Thyroid. 2010;20:453–8.

    Article  PubMed  Google Scholar 

  8. Shaha AR. Routine laryngoscopy in thyroid surgery: a valuable adjunct. Surgery. 2007;142:865–6.

    Article  PubMed  Google Scholar 

  9. Eng C, Mulligan LM, Smith DP, et al. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol. 1995;43:123–7.

    Article  CAS  Google Scholar 

  10. Miyauchi A, Hauptmann S, Dralle H. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg. 2002;26:1023–8.

    Article  PubMed  Google Scholar 

  11. Machens A, Hauptmann S, Dralle H. Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg. 2007;31:1960–5.

    Article  PubMed  Google Scholar 

  12. Kaserer K, Scheuba C, Heuhold N, et al. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol. 2001;25:1245–51.

    Article  CAS  PubMed  Google Scholar 

  13. Costante G, Meringolo D, Durante C, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92:450–5.

    Article  CAS  PubMed  Google Scholar 

  14. Barbet J, Campion L, Kraeber-Bodere F, Chatal JF. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:6077–84.

    Article  CAS  PubMed  Google Scholar 

  15. Benej M, Bendlova B, Vaclavikova E, Poturnajova M. Establishing high resolution melting analysis: method validation and evaluation for c-RET proto-oncogene mutation screening. Clin Chem Lab Med. 2012;50:51–60.

    Article  CAS  Google Scholar 

  16. Yip L, Cote GJ, Shapiro SE, et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg. 2003;138:409–16.

    Article  CAS  PubMed  Google Scholar 

  17. Rowland KJ, Chernock RD, Moley JF. Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening. J Surg Oncol. 2013;108:203–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946–54.

    Article  PubMed  Google Scholar 

  19. Solorzano CC, Carneiro DM, Ramirez M, et al. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg. 2004;70:576–80.

    PubMed  Google Scholar 

  20. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92:3590–4.

    Article  CAS  PubMed  Google Scholar 

  21. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg. 1999;229:880–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.

    Article  PubMed  Google Scholar 

  23. National Comprehensive Cancer Network. Thyroid Carcinoma (Version 2.2015). http://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed 21 Sept 2015.

  24. Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2655–63.

    Article  CAS  PubMed  Google Scholar 

  25. Giraudet AL, Vanel D, Leboulleux S, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab. 2007;92:4185–90.

    Article  CAS  PubMed  Google Scholar 

  26. Lesnik D, Cunnane ME, Zurakowski D, et al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck. 2014;36:191–202.

    Article  PubMed  Google Scholar 

  27. Gotthardt M, Battmann A, Hoffken H, et al. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun. 2004;25:439–43.

    Article  CAS  PubMed  Google Scholar 

  28. Tung WS, Vesely TM, Moley JF. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery. 1995;118:1024–9.

    Article  CAS  PubMed  Google Scholar 

  29. Callender GG, Hu MI, Evans DB, Perrier ND. Medullary thyroid carcinoma. In: Morita SY, Dackiw APB, Zeiger MA, editors. Manual of endocrine surgery. McGraw-Hill; 2010. p. 89–109.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Yale University School of Medicine, New Haven, CT, USA

    Glenda G. Callender

  2. Section of Endocrine Surgery, Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA

    Tracy S. Wang

Authors
  1. Glenda G. Callender
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracy S. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Glenda G. Callender .

Editor information

Editors and Affiliations

  1. Associate Professor of Surgery; Chief, Section of Endocrine Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Tracy S. Wang

  2. Donald C. Ausman Family Foundation Professor in Surgery and Chair, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Douglas B. Evans

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Callender, G.G., Wang, T.S. (2016). Preoperative Evaluation of the Patient with Medullary Thyroid Cancer. In: Wang, T., Evans, D. (eds) Medullary Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-39412-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39412-1_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39410-7

  • Online ISBN: 978-3-319-39412-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation